Scholar Rock

Director, Program Management, Next Wave

Cambridge, MA · Director

Sponsorship not specified$215k-$250kDetected 35 days ago

Project ManagementClinical TrialsLeadershipCommunication

About the role

As a global leader in myostatin biology, a field focused on proteins that regulate muscle mass, the Company is named for the visual resemblance of a scholar rock to protein structures.
Learn more at ScholarRock.com and follow @ScholarRock on X and on LinkedIn.
The Next Wave team is responsible for advancing Scholar Rock's portfolio of pipeline programs from translation to clinical proof-of concept.

Meeting Governance & Rigor: Own the architecture of Team interactions. This involves more than scheduling
you will drive the agenda to ensure decision-making, personally capture and disseminate critical actions, and relentlessly follow up to ensure completion.
Proactive Risk Mitigation: Build and maintain integrated program plans that drive performance through critical path planning and identification of risks.
Serve as the team's early warning system for operational risks - particularly those in the "white space" between functions - and drive them to resolution before they impact the critical path.
Portfolio Ownership: Support the early pipeline beyond any single study.
You will help the team and Program Lead manage the complexity of advancing multiple programs in the context of shared resources & infrastructure, ensuring focus on the critical path for each.
Professional Orientation: A low-ego, high-output mindset. You prioritize team success over hierarchy and demonstrate a willingness to own tasks of all sizes-from strategic planning to administrative execution-to ensure the program succeeds.
Meeting Governance & Rigor: Own the architecture of Team interactions.
This involves more than scheduling; you will drive the agenda to ensure decision-making, personally capture and disseminate critical actions, and relentlessly follow up to ensure completion.
Own the architecture of Team interactions.

You will provide the feasibility assessments and data required to evaluate trade-offs and make informed business decisions.
MS or BS Degree in a Scientific or related field
Minimum of 8 years of experience in pharmaceutical or biotechnology drug development, with specific experience leading teams through Ph1 and Ph2 clinical study start-up
Must possess a strong knowledge of early-to-mid stage clinical development including regulatory milestones, clinical operation activities and CMC needs.
The ideal candidate has experience across the drug lifecycle, from translation to Ph2 clinical trials, and understands how program needs evolve.
Demonstrated ability to handle confidential and potentially material information with professional judgment and integrity.
Pipeline Skillset: Must possess a strong knowledge of early-to-mid stage clinical development including regulatory milestones, clinical operation activities and CMC needs.
Technical Proficiency: Day-one ability to develop and implement project management best-practices utilizing project management tools (e.g., Smartsheet, MS Project)

Scholar Rock is a late-stage global biopharmaceutical company focused on developing and commercializing apitegromab for children and adults with spinal muscular atrophy (SMA) and other rare, severe, and debilitating neuromuscular diseases.
Our commitment to unlock fundamentally different treatment approaches is powered by broad application of a proprietary platform, which has developed novel monoclonal antibodies to modulate protein growth factors with extraordinary selectivity.
Scholar Rock works every day to create new possibilities for patients through its highly innovative anti-myostatin program, including opportunities in additional rare neuromuscular diseases.

This listing is sourced directly from Scholar Rock's careers page and normalized into a canonical job model.